Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cannabinoids. I. Behavioral effects.

P Stark, P B Dews

    The Journal of Pharmacology and Experimental Therapeutics
    |July 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    New cannabinoids, nabilone and canbisol, show varied behavioral effects in animal models, differing from delta 9-tetrahydrocannabinol (delta 9-THC) and chlordiazepoxide. Their unique profiles suggest distinct mechanisms of action in the central nervous system.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Search for Fractionally Charged Particles with CUORE.

    Physical review letters·2025
    Same author

    Multicenter Ozone Study in oldEr Subjects (MOSES): Part 1. Effects of Exposure to Low Concentrations of Ozone on Respiratory and Cardiovascular Outcomes.

    Research report (Health Effects Institute)·2020
    Same author

    Transfusion service management of sickle-cell disease patients.

    Vox sanguinis·2015
    Same author

    Memorial minute for B. F. Skinner.

    The Behavior analyst·2012
    Same author

    Activity anorexia: An interplay between basic and applied behavior analysis.

    The Behavior analyst·2012
    Same author

    New data base program for quality control of strabismus surgery.

    Strabismus·2011
    Same journal

    Striatal remodeling in Parkinson disease.

    The Journal of pharmacology and experimental therapeutics·2026
    Same journal

    Loaded and coated: Outer membrane vesicles get a critical boost from a lipopolysaccharide adjuvant payload in a rationally designed anti-Helicobacter pylori nanoparticle.

    The Journal of pharmacology and experimental therapeutics·2026
    Same journal

    Comparative analysis of ligand binding affinities and functional profiles at recombinant human β-adrenergic receptor subtypes 1, 2, and 3.

    The Journal of pharmacology and experimental therapeutics·2026
    Same journal

    Decoding the oncogenic functions and translational potential of Twinfilin-1.

    The Journal of pharmacology and experimental therapeutics·2026
    Same journal

    Antiproliferative effects of HIV integrase strand transfer inhibitors in experimental models for cancer research: A narrative review.

    The Journal of pharmacology and experimental therapeutics·2026
    Same journal

    Modulation of morphine tolerance and dependence by pyrroloquinoline quinone in mice: Insights into mechanistic bridge from N-methyl-D-aspartate receptors-calcium/calmodulin-dependent protein kinase II signaling to oxidative neuroinflammation.

    The Journal of pharmacology and experimental therapeutics·2026
    See all related articles

    Area of Science:

    • Neuropharmacology
    • Behavioral Neuroscience
    • Cannabinoid Research

    Background:

    • Delta 9-tetrahydrocannabinol (delta 9-THC) is a well-known cannabinoid with established psychoactive effects.
    • Chlordiazepoxide is a benzodiazepine anxiolytic with known effects on behavior and reactivity.
    • Nabilone and canbisol are novel cannabinoids whose comparative behavioral pharmacology remains to be fully elucidated.

    Purpose of the Study:

    • To compare the behavioral effects of two novel cannabinoids, nabilone and canbisol, against delta 9-tetrahydrocannabinol (delta 9-THC) and chlordiazepoxide.
    • To assess these effects across multiple animal models, including mice, rats, dogs, and rhesus monkeys.
    • To characterize the dose-dependent and species-specific activity profiles of these compounds.

    Main Methods:

    Related Experiment Videos

    • Behavioral testing in mice using photocell activity monitoring.
    • Assessment of muricide, intracranial self-stimulation, and reactivity in septal-lesioned rats.
    • Evaluation of ataxia in dogs via intravenous and oral administration.
    • Analysis of operant responding in rhesus monkeys under fixed-ratio fixed-interval schedules.

    Main Results:

    • Nabilone and canbisol decreased initial activity in mice, unlike delta 9-THC and chlordiazepoxide, and increased subsequent low activity.
    • In rats, delta 9-THC, nabilone, and canbisol inhibited muricide and intracranial self-stimulation, while nabilone, canbisol, and chlordiazepoxide reduced reactivity in septal-lesioned rats.
    • Nabilone and canbisol were the only compounds to reduce food consumption in rats; they also induced ataxia in dogs at lower doses than delta 9-THC.
    • While all cannabinoids initially increased responding in rhesus monkeys, higher doses reduced it, with canbisol abolishing responding at a lower dose than delta 9-THC or nabilone.

    Conclusions:

    • Nabilone and canbisol exhibit distinct behavioral profiles compared to delta 9-THC and chlordiazepoxide across various species.
    • These novel cannabinoids share some behavioral similarities with both delta 9-THC and chlordiazepoxide, suggesting complex interactions with the central nervous system.
    • The differential effects highlight the potential for nabilone and canbisol to serve as valuable pharmacological tools for studying cannabinoid receptor function and related pathways.